A study led by The University of Western Australia has shown that maps routinely produced to track the spread of diseases such as COVID-19 are flawed, resulting in inaccurate targeting of interventions and misallocation...
The first coronavirus 2019 (COVID-19) vaccine to be considered for emergency approval may be a month away. Pfizer chief executive officer Albert Bourla wrote in an open letter Friday morning that efficacy and safety...
Vaccines are traditionally administered with a needle, but this isn’t the only way. For example, certain vaccines can be delivered orally, as a drop on the tongue, or via a jet-like device. Vaccines that appear...
The Global Virus Network (GVN), a coalition of the world’s leading medical and basic virology research centers working to prevent illness and death from viral disease, convened a press conference with attendees from...
Science offers solutions but they will be ineffective without solidarity, says WHO chief Although 1 million lives are confirmed to have been lost to COVID-19, the real number is “certainly higher,” the chief of the...
Researchers analyzed blood and cerebrospinal fluid from 100 infants in Uganda with hydrocephalus A newly discovered bacteria may be working with a common virus to cause a serious brain condition in infants in Uganda...
Whether flu or coronavirus, it can take several days for the body to ramp up an effective response to a viral infection. New research appearing in the journal Nature Immunology describes how different cells in the...
Finding a vaccine for COVID-19 does not mean an automatic return to normality, experts say, warning people to be “realistic” about the challenges that remain. There may still be some time before it makes a...
The world is soon likely to confront a serious new challenge to the fight against Covid-19: vaccine hesitancy. In the U.S. and U.K., large numbers of people — at least 30 percent — have said in recent surveys that they...
A new study conducted by IVI in collaboration with SK bioscience shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children 6-23 months of age, a group...